Review
Jul 2026
In vivo engineering of CAR immune cells by nonviral nanoparticles.
Nonviral NPs are poised to redefine CAR therapy by enabling scalable, off-the-shelf immune interventions for cancer, autoimmune, and fibrotic diseases.
Ke Huang, Hao Wang, Tao Zhu et al.
· Biomaterials · 1 citation